Innospec

US · IOSP #2663 by market cap Listed 1970

97.42 -1.13 -1.15%

Live - 5344 symbols - heartbeat 47s ago · 2026-10-08 04:29

Pre-market 97.39 -0.03%

After-hours 97.42 0.00%

Market cap: 2.40B
P/E (TTM): 19.88
P/B: 1.79
EPS: 4.67
Div yield: 1.84%
52W pos: 91%

Reader sentiment Are you bullish or bearish on IOSP?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 5.40, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year -3.65% YoY

Margins

Gross margin: 27.69%
Operating margin: 8.79%
Net margin: 6.56%

Key ratios & quality

Altman Z-Score: 5.40

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	1.48B	1.51B	1.19B	1.48B	1.96B	1.95B	1.85B	1.78B
Gross profit	435.00M	466.20M	342.70M	434.90M	586.70M	591.10M	542.90M	492.40M
Selling & admin expenses	261.00M	280.90M	237.00M	267.20M	360.70M	380.50M	305.30M	285.10M
Research & development	33.40M	35.40M	30.90M	37.40M	38.70M	49.00M	56.50M	51.00M
Operating profit	140.60M	149.90M	74.80M	130.30M	187.30M	161.60M	181.10M	156.30M
Pretax profit	131.60M	150.40M	39.70M	134.40M	184.60M	174.40M	41.20M	138.10M
Tax	46.60M	38.20M	11.00M	41.30M	51.60M	35.30M	5.60M	21.50M
Net profit	85.00M	112.20M	28.70M	93.10M	133.00M	139.10M	35.60M	116.60M
Basic EPS	3	5	1	4	5	6	1	5
Diluted EPS	3.45	4.54	1.16	3.75	5.32	5.56	1.42	4.67

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	440.80M	439.70M	441.90M	455.60M	453.20M	491.40M
Gross profit	125.10M	123.20M	116.70M	127.40M	123.50M	138.30M
Selling & admin expenses	69.30M	74.60M	71.90M	69.30M	78.50M	84.30M
Research & development	12.70M	13.60M	13.70M	11.00M	13.20M	14.20M
Operating profit	43.10M	35.00M	31.10M	47.10M	31.80M	39.80M
Pretax profit	45.20M	32.30M	11.50M	50.30M	39.90M	41.60M
Tax	11.60M	8.40M	-1.40M	2.90M	9.10M	10.40M
Net profit	33.60M	23.90M	12.90M	47.40M	30.80M	31.20M
Basic EPS	1	1	1	2	1	1
Diluted EPS	1.31	0.94	0.52	1.91	1.22	1.25

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	663.90M	630.30M	566.20M	728.10M	872.60M	885.70M	956.60M	1.00B
Cash & ST investments	123.10M	75.70M	105.30M	141.80M	147.10M	203.70M	289.20M	292.50M
Inventory	248.00M	244.60M	220.00M	277.60M	373.10M	300.10M	301.00M	329.30M
Total assets	1.47B	1.47B	1.40B	1.57B	1.60B	1.71B	1.73B	1.83B
Total current liabilities	296.60M	303.50M	252.40M	336.60M	405.80M	371.50M	371.40M	360.10M
Short-term debt	23.20M	11.60M	11.80M	12.50M	13.90M	13.60M	13.90M	15.90M
Long-term debt	186.20M	58.60M	--	--	--	--	--	--
Total liabilities	647,900,000.00	549,900,000.00	452,500,000.00	537,900,000.00	563,300,000.00	557,800,000.00	518,600,000.00	499,500,000.00
Total equity	825.50M	918.90M	944.90M	1.03B	1.04B	1.15B	1.22B	1.33B
Retained earnings	668.30M	755.50M	758.60M	822.90M	924.20M	1.03B	1.03B	1.10B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	977.10M	969.70M	988.80M	1.00B	999.10M	1.02B
Cash & ST investments	299.80M	266.60M	270.80M	292.50M	289.10M	250.20M
Inventory	315.40M	336.80M	345.20M	329.30M	321.50M	337.30M
Total assets	1.77B	1.81B	1.80B	1.83B	1.82B	1.85B
Total current liabilities	357.60M	337.40M	356.10M	360.10M	334.80M	368.10M
Short-term debt	14.00M	15.60M	16.00M	15.90M	15.10M	14.30M
Long-term debt	--	--	--	--	--	--
Total liabilities	508,900,000.00	504,600,000.00	496,500,000.00	499,500,000.00	467,600,000.00	495,200,000.00
Total equity	1.27B	1.30B	1.30B	1.33B	1.35B	1.35B
Retained earnings	1.06B	1.06B	1.07B	1.10B	1.13B	1.14B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	104.90M	161.60M	145.90M	93.20M	81.70M	207.30M	184.50M	138.30M
Depreciation & amortization	49.60M	47.60M	46.00M	42.70M	40.10M	39.30M	43.50M	43.60M
Free cash flow	74.80M	130.60M	116.20M	54.10M	39.40M	130.10M	122.20M	62.80M
Dividends paid	-21.70M	-25.00M	-25.60M	-28.80M	-31.70M	-35.10M	-38.80M	-42.40M
Stock buybacks / issuance	-300.00K	-1.20M	100.00K	9.30M	-3.70M	-200.00K	1.40M	-23.40M
Ending cash balance	123.10M	75.70M	105.30M	141.80M	147.10M	203.70M	289.20M	292.50M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	28.30M	10.50M	38.10M	61.40M	17.60M	7.20M
Depreciation & amortization	10.90M	11.10M	12.20M	9.40M	9.90M	10.00M
Free cash flow	12.70M	-6.10M	16.00M	40.20M	3.60M	-10.50M
Dividends paid	--	--	0	-21.60M	--	--
Stock buybacks / issuance	-4.60M	-8.30M	-10.60M	100.00K	-7.00M	-6.40M
Ending cash balance	299.80M	266.60M	270.80M	292.50M	289.10M	250.20M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	10.50	12.87	3.08	9.42	12.85	12.73	3.02	9.19
ROA %	5.90	7.63	2.00	6.27	8.38	8.40	2.07	6.54
ROIC %	8.71	11.31	3.01	9.17	12.44	12.23	2.91	8.85
5-year avg ROE %	14.29	13.23	9.58	8.88	9.74	10.19	8.22	9.44
EBIT margin %	9.38	10.26	3.48	9.16	9.46	8.29	9.81	8.79
FCF / sales %	5.06	8.63	9.74	3.65	2.01	6.68	6.62	3.53
Current ratio	2.24	2.08	2.24	2.16	2.15	2.38	2.58	2.79
Quick ratio	1.36	1.21	1.29	1.27	1.19	1.52	1.70	1.76
Debt / assets	14.31	6.30	2.92	2.27	2.82	2.65	2.59	2.88
LT debt / equity	22.75	8.82	3.07	2.24	3.03	2.75	2.56	2.78
Interest coverage	20.07	32.33	23.06	90.60	168.82	--	--	--
Revenue CAGR (3Y) %	13.42	19.65	-2.99	0.15	9.07	17.77	7.55	-3.26
Net income CAGR (3Y) %	-10.73	11.34	-22.56	3.08	5.83	69.23	-27.42	-4.29
FCF CAGR (3Y) %	-6.67	13.64	32.02	-10.24	-32.93	3.84	31.21	16.81

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	2.21	1.55	-0.09	9.19	8.77	9.21
ROA %	1.54	1.10	-0.07	6.54	6.35	6.65
ROIC %	2.13	1.49	-0.09	8.85	8.46	8.88
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	9.69	9.31	8.47	8.79	8.10	8.13
FCF / sales %	3.85	4.02	1.54	3.53	3.00	2.68
Current ratio	2.73	2.87	2.78	2.79	2.98	2.78
Quick ratio	1.80	1.79	1.74	1.76	1.92	1.79
Debt / assets	2.50	2.73	2.72	2.88	2.78	2.59
LT debt / equity	2.41	2.60	2.54	2.78	2.64	2.50
Interest coverage	--	--	--	--	--	--
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Diversified

Performance Chemicals is the largest reported line at 38.73% of revenue, across 3 reported segments.
No single line clears half of revenue; Fuel Specialties is next at 37.79%, spreading the business across more than one real driver.

Revenue breakdown most recent period

Business

Performance Chemicals38.73%

Fuel Specialties37.79%

Oilfield Services23.48%

Quote time 2026-10-08 04:29:19 · For reference only, not investment advice and not tailored to your situation.